![]() |
Today's News |
|
Vancouver's AbCellera Biologics Sets Terms for Monster IPO, Could Value the Company at Up to US $4.5 Billion (and Raise as Much as $391M US)
Tuesday, December 8, 2020
Vancouver, BC, December 8, 2020--AbCellera Biologics said that terms of its initial public offering have been set, which could value the artificial intelligence (AI)-powered drug discovery company at up to $4.52 billion. The Vancouver-based company, which is working with Eli Lilly & Co. on a COVID-19 therapy, said it is offering 23 million shares in the IPO, which is expected to price between $14 and $17 a share, which means the company could raise as much as $391 million and value the Compa
|
![]() |
![]() |
![]() |
Share |
|||
|
Member Toolbar |
![]() MarketWatch Posted: Dec 8, 2020 |
News Actions |
![]() |
Navigation |
![]() |
![]() |
|||||||||||||||||||
Hiring Today |
|||||||||||||||||||
See All Jobs |
|||||||||||||||||||
![]() |
Copyright © T-NET. All Rights Reserved. | https://www.bctechnology.com |
![]() |